CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities:
Net loss	$ (91,350)	$ (43,988)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation	49,420	54,201
Amortization	7,209	4,163
Straight-line rent adjustments	190	322
Deferred compensation	274	400
Gain on sale of preferred equity interest	0	(3,688)
Paid-in-kind interest	42,708	25,932
Gain on hedge ineffectiveness	(13)	(17)
Gain on sale of equity method investment	0	(9,053)
Gain on sales of interests in real estate	0	(1,701)
Gain on sales of interests in non operating real estate	(1,057)	(8,755)
Equity in loss of partnerships	6,682	1,583
Cash distributions from partnerships	850	3,725
Change in assets and liabilities:
Net change in other assets	14,624	12,600
Net change in other liabilities	3,608	(4,543)
Net cash provided by operating activities	33,145	31,181
Cash flows from investing activities:
Cash proceeds from sales of real estate	29,713	28,079
Investments in real estate improvements	(10,767)	(5,902)
Additions to construction in progress	(1,958)	(1,594)
Investments in partnerships	(152)	(587)
Capitalized leasing costs	(304)	(101)
Proceeds from sale of preferred equity interest	0	2,438
Additions to leasehold improvements and corporate fixed assets	(32)	(87)
Net cash provided by investing activities	16,500	22,246
Cash flows from financing activities:
Net borrowings (repayments) to the First Lien Revolving Facility	5,000	(38,471)
Net repayments to term loans	(26,312)	(19,766)
Repayments of finance lease liabilities	(348)	0
Principal installments on mortgage loans	(24,565)	(15,292)
Payment of deferred financing costs	(2,854)	(395)
Repurchase of shares retired under equity incentive plans, net of shares issued	(52)	(767)
Net cash used in financing activities	(49,131)	(74,691)
Net change in cash, cash equivalents, and restricted cash	514	(21,264)
Cash, cash equivalents, and restricted cash, beginning of period	34,689	58,077
Cash, cash equivalents, and restricted cash, end of period	$ 35,203	$ 36,813